Levetiracetam Tablet
Product Images NDC 70518-4301

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 70518-4301). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Levetiracetam 500 mg oral tablets packaging label. The label shows 30 tablets per container and is marked RX only. The labeler is RemedyRepack Inc., with manufacturing by Tris Pharma, Inc. Instructions note to see package insert for directions and provide storage temperature guidelines.*

FDA Label Image

Structure Formula (Levetiracetam Tablets 1)

Chemical structure of levetiracetam, showing its molecular framework with nitrogen, oxygen, carbon, and hydrogen atoms depicted along with a two-carbon ethyl side chain.*

FDA Label Image

Figure 1 (Levetiracetam Tablets 2)

A bar graph showing the percentage of patients for three groups: Placebo (7.4%), Levetiracetam 1000 mg/day (37.1%), and Levetiracetam 3000 mg/day (39.6%). The graph compares patient outcomes at different dosages of Levetiracetam versus placebo.*

FDA Label Image

Figure2 (Levetiracetam Tablets 3)

A bar chart comparing the percentage of patients across three groups: Placebo, Levetiracetam 1000 mg/day, and Levetiracetam 2000 mg/day. The chart shows increasing patient percentages from placebo (6.3%) to 1000 mg/day (20.8%) and 2000 mg/day (35.2%) dosage groups.*

FDA Label Image

Figure3 (Levetiracetam Tablets 4)

A bar chart comparing the percentage of patients between two groups: Placebo (N=104) and Levetiracetam 3000 mg/day (N=180). The chart shows approximately 14.4% for the Placebo group and 39.4% for the Levetiracetam group on the y-axis representing percentage of patients.*

FDA Label Image

Figure4 (Levetiracetam Tablets 5)

A bar chart comparing the percentage of patients in two groups: Placebo (N=97) and Levetiracetam (N=101). The y-axis shows percentage of patients, with Placebo at approximately 19.6% and Levetiracetam at 44.6%. An asterisk marks the Levetiracetam bar, indicating statistical significance or notable difference.*

FDA Label Image

Figure5 (Levetiracetam Tablets 6)

A bar chart comparing the percentage of patients between two groups: placebo (N=51) and levetiracetam (N=58). The chart shows approximately 19.6% of patients in the placebo group and 43.1% in the levetiracetam group, with a marker indicating a significant data point in the levetiracetam bar.*

FDA Label Image

Figure6 (Levetiracetam Tablets 7)

Bar chart comparing the percentage of patients between two groups: Placebo (N=84) with 45.2% and Levetiracetam (N=79) with 72.2%. The y-axis represents the percentage of patients from 0% to 100%.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.